NCT04204811Active, not recruiting
Prehabilitation Care for Women With Advanced Ovarian Cancer Receiving Neoadjuvant Chemotherapy
A Pilot Project to Evaluate Feasibility and Patient Experience of Prehabilitation Care for Women With Advanced Ovarian Cancer Undergoing Neoadjuvant Chemotherapy
Source: ClinicalTrials.gov · Last updated 7 Jan 2026
Brief summary (registry, in English)
The purpose of this study is evaluate whether a prehabilitation program is feasible and useful for women with advanced ovarian cancer receiving chemotherapy in preparation for debulking surgery.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 22 (estimated)
- First submitted
- 17 Dec 2019
- Start date
- 16 Dec 2019
- Primary completion date
- 16 Dec 2026
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Diseases
- Ovarian cancer
- NCT number
- NCT04204811
What you commit to
- Study type: Interventional
- Planned participants: 22
- From 16 Dec 2019 to the primary completion date, 16 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Prior treatment for ovarian cancer
- Immediate surgery plan without neoadjuvant treatment
- No intended surgical plan
- Chemotherapy administration exclusively planned at MSKCC regional site
Age
- Patient under age 18
Other
- Second opinion visit only
- Patient unwilling to sign consent
Who the study is looking for
- Subjects must be diagnosed with Stage III or Stage IV ovarian carcinoma (which includes primary peritoneal carcinoma or fallopian rube carcinoma)
- All subjects must be enrolled within 90 days of diagnosis
- No prior treatment for ovarian carcinoma
- All subjects have agreed to a treatment plan of neoadjuvant chemotherapy and subsequent planned interval debulking surgery with an MSKCC surgeon
- Participants must be initiating treatment at Gynecologic Medical Oncology clinics at MSKCC Manhattan
- Proficiency in English in the determination of the investigators of by patient self-report
Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Memorial Sloan-Kettering Cancer Center Coordinator of this site? Confirm its status | New York | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.